Hormonal Therapy and the Risk of Rheumatic Autoimmune Diseases in Older Men with Prostate Cancer
Author Information
Author(s): Albayyaa Mohanad
Primary Institution: The University of Texas Medical Branch, Galveston, Texas, United States
Hypothesis
Is there a link between hormonal therapy and rheumatic autoimmune diseases among older men with prostate cancer?
Conclusion
Hormonal therapy is associated with a higher risk of rheumatic autoimmune diseases in older men with prostate cancer.
Supporting Evidence
- Hormonal therapy alters immune cell regulation and may increase the risk of autoimmune diseases.
- Kaplan-Meier analysis showed higher rates of rheumatic autoimmune diseases among patients receiving hormonal therapy.
Takeaway
Older men with prostate cancer who receive hormonal therapy might get sick with autoimmune diseases more often than those who don't.
Methodology
Analyzed a cohort of patients aged 66 years or older diagnosed with localized prostate cancer using Texas Cancer Registry Linked to Medicare dataset.
Participant Demographics
Patients aged 66 years or older with localized prostate cancer.
Statistical Information
P-Value
HR = 1.29
Confidence Interval
95% CI: 1.17-1.56
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website